Clinical research

Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis

EuroIntervention 2010;5 939-945.

N Melikian
Narbeh Melikian1,2, BSc, MD, MRCP; Stephen Vercauteren1, MD; William F. Fearon3, MD; Thomas Cuisset1, MD; Philip A. MacCarthy4, MB BCh, PhD, FRCP; Giedrius Davidavicius1, MD; Wilbert Aarnoudse5, MD; Jozef Bartunek1, MD, PhD; Marc Vanderheyden1, MD, PhD; Eric Wyffels1, MD; William Wijns1, MD, PhD; Guy R. Heyndrickx1, MD, PhD; Nico H. J. Pijls5, MD, PhD; Bernard De Bruyne1*, MD, PhD
1. Cardiovascular Center, OLV Hospital, Aalst, Belgium; 2. Cardiology Department, King’s College London School of Medicine, London, United Kingdom; 3. Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA, USA; 4. Cardiolog

Aims: The influence of atherosclerosis and its risk factors on coronary microvascular function remain unclear as current methods of assessing microvascular function do not specifically test

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary microcirculationindex of microvascular resistance (imr)fractional flow reserve (ffr)atherosclerosis
Read next article
Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial

Latest news